Navigation Links
GlaxoSmithKline Wins Environmental Stewardship Award
Date:2/24/2011

NAPERVILLE, Ill., Feb. 24, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK), one of the world's leading pharmaceutical companies, has received the 2010 Environmental Stewardship Award from Nalco Company (NYSE: NLC) in recognition of GSK's ongoing efforts to reduce its climate change impact and energy and water use.

(Logo: http://photos.prnewswire.com/prnh/20101231/NALCOLOGO)

The Environmental Stewardship Award recognizes exceptional performance in achieving sustainability objectives and financial goals.  "The award targets global enterprises that set aggressive environmental commitments," said Emilio Tenuta, Nalco's Director of Sustainability.  "In addition, it recognizes companies that go beyond measuring performance and embrace a mindset of continuous improvement to help achieve or surpass their targets by leveraging the partnerships of experts in the industry."

In 2006, GSK set targets to reduce its water consumption by 2 percent per year by 2010.  By 2009, water consumption had been decreased 15 percent, significantly exceeding those goals.  In addition, in 2007 GSK launched a climate change program for its operations, setting targets to reduce energy use by 45 percent per unit of sales by 2015, using 2006 figures as a benchmark.  

Richard Pamenter, Vice President and Head of GSK's Environmental Sustainability Centre of Excellence said, "GSK is pleased to receive this award from Nalco as it reinforces our commitment to environmental sustainability, which is essential to our role as a good corporate citizen.  It makes business sense too.  If we continue to develop these relationships – with Nalco, for example – and establish others, we will continue to show how GSK is focused on doing the right thing."

The annual Environmental Return on Investment (eROI) that GSK has achieved from using Nalco's sustainable solutions includes:

  • more than 325,000 cubic meters (85.8 million gallons) of water savings, enough for the annual water needs of nearly 3,400 people,
  • 4.1 million kWh of energy savings, equal to 147 households annual use, and
  • 2,000 metric tonnes of CO2 reduction, equal to more than 83,000 trees.

These environmental improvements also resulted in financial savings for GSK of more than pounds Sterling 1.3 million since 2008.

The award selection committee included Nalco representatives and input from the Water Innovation Alliance (WIA).  

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com.

About Nalco

Nalco is the world's largest sustainability services company focused on industrial water, energy and air applications; delivering significant environmental, social and economic performance benefits to our customers.  We help our customers reduce energy, water and other natural resource consumption, enhance air quality, minimize environmental releases and improve productivity and end products while boosting the bottom line.  Together our comprehensive solutions contribute to the sustainable development of customer operations.  Nalco is a member of the Dow Jones Sustainability Indexes.  More than 12,000 Nalco employees operate in 150 countries supported by a comprehensive network of manufacturing facilities, sales offices and research centers to serve a broad range of end markets.  In 2010, Nalco achieved sales of $4.25 billion.  For more information, visit www.nalco.com.

Follow us on Twitter at www.twitter.com/Nalco_News and www.twitter.com/NalcoCompany.

About Water Innovations Alliance

The Water Innovations Alliance is an industry association focused on developing new funding, reducing regulatory barriers, increasing collaboration and raising awareness for cutting-edge water technologies and the problems they solve.  The Alliance serves the entire spectrum of the water sector: corporations, investors, engineering firms, start-ups, NGOs, research centers, municipalities, and others in the field.  It is a 501(c)(6) trade organization.  To learn more about the Alliance visit www.waterinnovations.org.


'/>"/>
SOURCE Nalco
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits
2. GlaxoSmithKline Applauds North Carolinas Child Advocates
3. A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
4. Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
5. GlaxoSmithKline CEO Interviewed On Half-Year and Q2 Results
6. GlaxoSmithKline Statement in Response to FDA Advisory Committees Vote on Safety of Avandia® (rosiglitazone)
7. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
8. Johnson Controls Secures Global Facilities Management Win With GlaxoSmithKline
9. North Carolina GlaxoSmithKline Foundation Working With Nonprofits to Promote Health, Science and Education Through Ribbon of Hope Grants
10. Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease
11. GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... and PITTSBURGH, Feb. 10, 2016 Mylan N.V. (NASDAQ, ... quarter and year ended December 31, 2015. ... Full year adjusted total revenues of $9.45 billion, up ... year; GAAP total revenues of $9.43 billion. Excluding the ... markets specialty and branded generics business (the "EPD Business"), ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand ... within Healthcare, recently partnered with Heart City Health Center to improve ... 23 years, Heart City Health Center has provided the Elkhart community with access ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... 10 ... Brand. There were three leading bottled water brand owners that topped the list as ... enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):